Meloxicam

This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H13N3O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VG2QF83CGL, chemically known as 4-hydroxy-2-methyl-n-(5-methyl-2-thiazoyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide but generally known as meloxicam, which bears US NIH Compound Identifier 5281106. European Medicines Agency schedules Meloxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08726MIG. The term MELOXICAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules meloxicam in its Anatomical Therapeutic Chemical (ATC) Classification. MELOXICAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule meloxicam under HS 29341000 and SITC 51579. As of Q4 2014, MELOXICAM remains the US FDA Preferred Term for this commodity. Meloxicam bears US NLM identifiers UMLS ID C0083381 and NCI Concept Code C61439. SMILES: S1(=O)(=O)N(/C(=C(/O)NC2SC(CN2)C)C(=O)C2C1CCCC2)C.